为了向您推荐更精准的技术资料,请补充您的研发需求..... 前往补充

ANX Sepharose 4 Fast Flow (High Sub)

ANX Sepharose 4 Fast Flow (high sub) is a weak anion exchanger, with a different selectivity compared with traditional ion exchangers. It is optimized for the separation of larger proteins

马上购买
ANX Sepharose 4 Fast Flow (high sub) is a weak anion exchanger, with a different selectivity compared with traditional ion exchangers. It is optimized for the separation of larger proteins
  • Weak anion exchanger with different selectivity compared with traditional ion exchangers.
  • Applicable for separation of high molecular weight proteins.
  • Developed in co-operation with leading large-scale pharmaceutical manufacturers.
  • High chemical stability allows for well proven CIP and sanitization protocols.
  • The hydrophilic nature of the base matrix ensures low levels of non-specific binding leading to low levels of host cell-derived impurities in the elution pool.

ANX Sepharose Fast Flow (high sub) is part of the Sepharose Fast Flow ion exchange platform, which has been the industrial standard for ion exchange chromatography during recent decades. ANX Sepharose 4 Fast Flow (high sub) is a weak anion exchanger resin with tertiary amine groups attached to the base matrix Sepharose 4 Fast Flow via ether linkage and a hydrophilic spacer arm. The diethylaminopropylgroup is coupled in a mode that precludes formation of quaternary groups, which are typically seen on traditional DEAE media, resulting in a truly weak anion exchanger. The base matrix, Sepharose 4 Fast Flow, is a highly cross-linked, 4% agarose derivative with high chemical and physical stability and broad separation range. ANX Sepharose 4 Fast Flow (high sub) has high chemical stability, allowing well proven cleaning-in-place (CIP) and sanitization protocols.

As member of the BioProcess resin range, ANX Sepharose 4 Fast Flow (high sub) meets industrial demands with security of supply and comprehensive technical and regulatory support.

以LNP为载体的In vivo CAR-T应用进展

主讲嘉宾:向涛

课程分类:线上产品课程 – 细胞与基因治疗

  1. 以LNP为递送载体的In vivo CAR-T技术的全球管线情况介绍
  2. 以LNP为递送载体的In vivo CAR-T的最新研究与技术进展
  3. Cytiva在以LNP为载体的In vivo CAR-T应用方向上的整体解决方案

相关文档下载

相关产品推荐